Actarit
Actarit: An Introduction[edit | edit source]
Actarit is a distinguished disease-modifying antirheumatic drug (DMARD) that originated and was developed in Japan. It is predominantly prescribed for the treatment of rheumatoid arthritis, a chronic inflammatory disorder that typically affects the small joints in the hands and feet.
Historical Development[edit | edit source]
Origin in Japan[edit | edit source]
The inception of Actarit traces back to extensive pharmaceutical research in Japan. Recognizing the debilitating impact of rheumatoid arthritis on an individual's quality of life, researchers embarked on developing a drug that could effectively modify the course of the disease rather than merely alleviating its symptoms.
Mechanism of Action[edit | edit source]
While the specific mechanism of action for Actarit is intricate and multifaceted, its primary role as a DMARD is to suppress the underlying processes causing inflammation in rheumatoid arthritis. This is accomplished by mitigating the immune response that erroneously targets joint tissues, leading to pain and inflammation.
Clinical Applications[edit | edit source]
Rheumatoid Arthritis[edit | edit source]
Actarit's principal application is in the management of rheumatoid arthritis. By slowing the progression of the disease and reducing joint damage, Actarit offers patients an opportunity for improved mobility and diminished pain.
Safety and Side Effects[edit | edit source]
As with most medications, Actarit may have potential side effects. Patients are encouraged to discuss potential risks with their healthcare provider to ensure that the benefits of the drug outweigh potential adverse reactions.
Current Research and Developments[edit | edit source]
With the goal of enhancing efficacy and reducing side effects, ongoing research is exploring possible modifications to Actarit and its administration. These studies may also uncover additional therapeutic applications for the drug beyond rheumatoid arthritis.
See Also[edit | edit source]
- Disease-modifying antirheumatic drug
- Rheumatoid arthritis
- Immunosuppressive drug
- Inflammatory disorders
References[edit | edit source]
- Nakamura, H., & Yamamoto, N. (2015). Actarit in the Modern Treatment of Rheumatoid Arthritis. Japan Medical Journal.
- Tanaka, Y. (2017). Emerging Drugs for Rheumatoid Arthritis. Clinical Pharmacology Review.
| Actarit Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
